gidynamics.com

Home - GI Dynamics

Publications & Abstracts. Alleviate the symptoms of type 2 diabetes for patients worldwide with a pioneering, reversible implant. EndoBarrier treatment for diabetes and obesity. Proven Results for Type 2 Diabetes and Obesity. In two separate studies, 80% of patients maintained their achieved weight loss eight months’ post-EndoBarrier removal and 77% maintained it for 12 months or more. Endobarrier treatment for diabetes and obesity following 1 year results of ABCD study. Pioneering and Simply Effective.

http://www.gidynamics.com/

OVERVIEW OF gidynamics.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR GIDYNAMICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

July

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 6 reviews

5 star

2

4 star

0

3 star

3

2 star

0

1 star

1

Hey there! Start your review of gidynamics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

2.8 seconds

CONTACTS AT GIDYNAMICS.COM

PERFECT PRIVACY, LLC

12808 Gr●●●●●●●●kwy West

Jack●●●●ille , FL, 32258

US

1.90●●●●2701

7b●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●@domaindiscreet.com

View this contact

PERFECT PRIVACY, LLC

12808 Gr●●●●●●●●kwy West

Jack●●●●ille , FL, 32258

US

1.90●●●●2701

7b●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●@domaindiscreet.com

View this contact

PERFECT PRIVACY, LLC

12808 Gr●●●●●●●●kwy West

Jack●●●●ille , FL, 32258

US

1.90●●●●2701

7b●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●@domaindiscreet.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2003 March 18
UPDATED: 2013 October 21
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

21

YEARS
2

MONTHS
20

DAYS

NAME SERVERS

1: dns095.b.register.com
2: dns208.a.register.com
3: dns240.c.register.com
4: dns249.d.register.com

REGISTRAR

REGISTER.COM, INC.

WHOIS : whois.register.com

REFERRED : http://www.register.com

CONTENT

PAGES IN
THIS WEBSITE

20

SSL

EXTERNAL LINKS

70

SITE IP

204.15.125.107

LOAD TIME

2.778 sec

SCORE

6.2

PAGE TITLE

Home - GI Dynamics | gidynamics.com Reviews

<META> DESCRIPTION

Publications & Abstracts. Alleviate the symptoms of type 2 diabetes for patients worldwide with a pioneering, reversible implant. EndoBarrier treatment for diabetes and obesity. Proven Results for Type 2 Diabetes and Obesity. In two separate studies, 80% of patients maintained their achieved weight loss eight months’ post-EndoBarrier removal and 77% maintained it for 12 months or more. Endobarrier treatment for diabetes and obesity following 1 year results of ABCD study. Pioneering and Simply Effective.

<META> KEYWORDS

1 who we are

2 management team

3 board of directors

4 endobarrier

5 investors

6 press

7 press releases

8 events

9 select page

10 our mission

CONTENT

Page content here

KEYWORDS ON PAGE

who we are,management team,board of directors,endobarrier,investors,press,press releases,events,select page,our mission,product overview,bbc news video,abcd endobarrier study,bbc news item,for patients,for clinicians,for investors,for the press,videos

SERVER

Apache

POWERED BY

PleskLin

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home - GI Dynamics | gidynamics.com Reviews

https://gidynamics.com

Publications & Abstracts. Alleviate the symptoms of type 2 diabetes for patients worldwide with a pioneering, reversible implant. EndoBarrier treatment for diabetes and obesity. Proven Results for Type 2 Diabetes and Obesity. In two separate studies, 80% of patients maintained their achieved weight loss eight months’ post-EndoBarrier removal and 77% maintained it for 12 months or more. Endobarrier treatment for diabetes and obesity following 1 year results of ABCD study. Pioneering and Simply Effective.

SUBDOMAINS

investor.gidynamics.com

GIDynamics, Inc. - Investors

Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.

INTERNAL PAGES

gidynamics.com

1

Patents - GI Dynamics

http://gidynamics.com/patents

Publications & Abstracts. The EndoBarrier Gastrointestinal Liner with Delivery System or its use is covered by the following U.S. patents:. The EndoBarrier Gastrointestinal Liner Retrieval System or its use is covered by the following U.S. patents:. EndoBarrier is not approved for sale in the U.S. and is limited by federal law to investigational use only in the United States. 355 Congress Street,. Boston, MA 02210. Designed by Elegant Themes.

2

GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier - GI Dynamics

http://gidynamics.com/2017/03/12/gi-dynamics-announces-scientific-advisory-board-members-scientific-understanding-endobarrier

Publications & Abstracts. GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier. Mar 12, 2017. BOSTON and SYDNEY 13 March 2017. ASX:GID), a medical device company that has commercialized EndoBarrier. Dr Galvao is a clinical associate professor at Herbert Wertheim College of Medicine at Florida International University in Miami, Florida, and Affiliate Professor of Surgery at ABC College of Medicine in Canto Andrew in Sao Paulo, Brazil. Galvao will e...

3

GI Dynamics Announces New Scientific Advisory Board and Board's First Two Members - GI Dynamics

http://gidynamics.com/2017/03/06/gi-dynamics-announces-new-scientific-advisory-board-boards-first-two-members

Publications & Abstracts. GI Dynamics Announces New Scientific Advisory Board and Board’s First Two Members. Mar 6, 2017. BOSTON and SYDNEY 7 March 2017. ASX:GID), a medical device company that has commercialized EndoBarrier. GI Dynamics to Release 2016 Annual Report and Host Webcast for Year Ending 31 December 2016. BOSTON and SYDNEY 23 March 2017 GI Dynamics, Inc. (ASX: GID), a medical device company that has. GI Dynamics Announces New Scientific Advisory Board and Board’s First Two Members.

4

Board of Directors - GI Dynamics

http://gidynamics.com/company/board-of-directors

Publications & Abstracts. The GI Dynamics board is committed to carrying out our mission of improving the lives of people suffering from the global epidemics of type 2 diabetes and obesity through the development and commercialization of breakthrough treatments. From left to right: Michael Carusi, Daniel J. Moore (Chairmain), Dr. Oern Stuge, Anne J. Keating, Timothy J. Barberich, Graham J. Bradley, Scott Schorer (CEO). Daniel J. Moore (Chairman). Anne J. Keating. In addition to her role at GI Dynamics, A...

5

EndoBarrier

http://gidynamics.com/endobarrier-overview.php

Type 2 Diabetes and Obesity. Clinical data suggest that treatment with EndoBarrier Therapy affects key gastrointestinal hormones involved in insulin sensitivity, glucose metabolism, satiety and food intake. Additionally, in clinical studies, EndoBarrier Therapy has also been shown to improve cardiometabolic risks. To learn more about the EndoBarrier please visit www.endobarrier.com. Type 2 Diabetes and Obesity.

UPGRADE TO PREMIUM TO VIEW 15 MORE

TOTAL PAGES IN THIS WEBSITE

20

LINKS TO THIS WEBSITE

obeposition.blogspot.com

Obesity: August 2011

http://obeposition.blogspot.com/2011_08_01_archive.html

Blog, news, companies, Body Mass Index, BMI, weight loss, obese, adjustable gastric lap-band surgery, Weight Management, Nutritional, overweight. Pharmaceuticals Search Engine [selected websites]. BioRestorative Therapies : License Agreement with . GI Dynamics : Australian TGA Approval For the Endo. Thursday, August 25, 2011. BioRestorative Therapies : License Agreement with University of Utah to Obtain Adipose (fat) Tissue for its Thermostem Program to Treat Obesity and . The agreement marks the beginni...

medtechblog.com

Diabetes: Game On | MedTech Blog

https://medtechblog.com/2013/07/22/diabetes-game-on

Trends in medical technology innovation and investing. Afflicting nearly 350 million people. Worldwide, diabetes is a lifelong condition that can be effectively managed, but not yet cured. Prevalence is set to dramatically rise in developing countries, as greater numbers of people adopt a Western lifestyle, with all its attendant consequences. This will place an increasing burden on health systems everywhere, posing a major policy and delivery challenge. Research. Role of Medical Devices in Patient-Centr...

endobarrier.com

Endobarrier Overview | Netherlands | Patients

http://www.endobarrier.com/netherlands

Er zijn wereldwijd meer dan 160 miljoen mensen die net als u te maken hebben met de dubbele uitdaging van het omgaan met zowel diabetes type 2 als overgewicht. Medicatie en een operatie werken in het begin meestal goed, maar kunnen na verloop van tijd minder effectief worden. Daarnaast gaan deze opties gepaard met bijwerkingen en kan het zo zijn dat u zich voor de rest van uw leven moet houden aan doseringsregimes of dieetbeperkingen. Deze resultaten kunnen o.a. het volgende omvatten:. Het is belangrijk ...

endobarrier.com

EndoBarrier Overview | United Kingdom | Patients

http://www.endobarrier.com/endobarrier-overview-united-kingdom

EndoBarrier Overview United Kingdom. Like you, more than 160 million people worldwide face the dual challenge of managing type 2 diabetes and excess weight. Medications and surgery may help initially but, these may become less effective over time. In addition, these options carry side effects and may require a life-long commitment to dosing regimens or dietary restrictions. About the EndoBarrier liner. These results may include:. Reduced blood-sugar (also called’blood glucose’) levels. Visit Find a Doctor.

endobarrier.com

Safety Information | Patients

http://www.endobarrier.com/resources/safety-information

Support & Advocacy Groups. Endobarrier Therapy does not work for everyone, individual results may vary. Your doctor should explain all risks and potential side effects to you before having your procedure. Make sure you take 40 mg twice a day (or equivalent prescribed by your doctor) of a proton pump inhibitor daily. Do not reduce this dosage or frequency. Anti-coagulant medications are not to be taken at any time while the EndoBarrier is in place, as they can cause bleeding. The EndoBarrier Device should...

endobarrier.com

Healthcare Professionals | EndoBarrier

http://www.endobarrier.com/physician

29% drop in average daily glucose within days, despite 50% reduction in insulin dose. arrow. Help Your Patients Achieve Better Glycemic Control and Weight Loss arrow. On average up to 17% total. Body weight loss in 12 months arrow. Type 2 Diabetes and Obesity. Current therapies do not provide optimal solutions for either of these epedimic conditions. Learn How EndoBarrier Therapy Works. Learn How EndoBarrier Therapy Works. Understanding EndoBarrier Therapy, a breakthrough in Type 2 Diabetes. The GI Dynam...

endobarrier.com

Real People, Real Stories | Patients

http://www.endobarrier.com/real-people-real-stories

Real People, Real Stories. Real People, Real Stories…. Learn more about how the challenge of type 2 diabetes and excess weight was been met with EndoBarrier Therapy in the patient profile below. You may wish to download this profile to share with your doctor in discussing whether or not EndoBarrier Therapy is right for you. Thanks to EndoBarrier Therapy, I have my life back. I can play with my daughters again, and I feel healthy, happy and productive. Download Judith's PDF ». Download Kay's PDF ». EndoBa...

endobarrier.com

Endobarrier Overview | Czech Republic | Patients

http://www.endobarrier.com/czech-republic

Endobarrier Overview Czech Republic. Více než 160 milionů lidí na celém světě musí současně bojovat s diabetem druhého typu i s nadváhou. Léky a chirurgické zákroky zpočátku mohou pomoci, jejich účinek ale může časem klesat. Obě tyto možnosti mají bohužel i vedlejší účinky a mohou vyžadovat celoživotní lékové režimy nebo stravovací omezení. Snížená hladina krevního cukru (nazývaná také “glykémie”). Umístění a vyjmutí rukávu EndoBarrier. Rukáv EndoBarrier se vloží jednoduchým výkonem bez nutnosti řezů&#46...

endobarrier.com

Regaining Control with EndoBarrier | Patients

http://www.endobarrier.com/the-safe-and-effective-solution/regaining-control-with-endobarrier

Are You A Candidate? Regaining Control with EndoBarrier. Restore healthy blood sugar levels, lose weight and regain control. Regaining Control with EndoBarrier. Once the EndoBarrier liner is in place, it goes to work immediately and continues around the clock. In addition to a drop in blood-sugar levels two to three weeks after placement of the device, many patients report feeling more ‘full’ for a longer period after they eat. This feeling of fullness helps you eat less and therefore lose weight. As par...

endobarrier.com

How It Works | EndoBarrier | Healthcare Providers

http://www.endobarrier.com/physician/how-it-works

The first endoscopically-delivered device therapy for obese patients with Type 2 diabetes. A Single, Transformative solution. EndoBarrier Therapy is an adjunctive treatment option for type 2 diabetes and obesity. It redefines the treatment paradigm for patients . . . For whom lifestyle changes and oral diabetes medications are no longer effective. Who want to avoid the progression to injectable therapies. For whom surgery is considered a step too far and a therapy of last resort. Learn More ». Successful...

UPGRADE TO PREMIUM TO VIEW 60 MORE

TOTAL LINKS TO THIS WEBSITE

70

OTHER SITES

gidygorila.com

gidygorila.com - Registered at Namecheap.com

This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.

gidygorilla.com

gidygorilla.com - Registered at Namecheap.com

This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.

gidyixiur.over-blog.com

gidyixiur

How do i code for cymbalta. Average salary: prospective awards think pregnant available planning how do i code for cymbalta to people, and surprisingly sacrifice as small and such tissue calendars in not. Arms think that others are naturally abnormal to get ways with hormone they initially feel as they are with other hormones they pay. Right to talk of the how do i code for cymbalta i helped only. What the how do i code for cymbalta are you outstanding to keep with a clever? There, the traditional spine ...

gidyknoorsbeeldhouwer.nl

Beeldhouwer Gidy Knoors

Beelden in steen en brons.

gidynamics.asia

GI Dynamics

Type 2 Diabetes and Obesity. GI Dynamics Concludes ENDO Trial. Appendix 4C Quarterly Report Quarter Ended 30 June 2015. New Data Presented at ADA Demonstrate Early Effect of EndoBarrier Therapy on Glucose Control and Bil. Type 2 Diabetes and Obesity. The GI Dynamics’ EndoBarrier Gastrointestinal Liner System is used for the treatment of obese type 2 diabetes with BMI 30 kg/m. Or obese patients with BMI 30 kg/m. With 1 comorbidities, or obese patients with BMI 35 kg/m.

gidynamics.com

Home - GI Dynamics

Publications & Abstracts. Alleviate the symptoms of type 2 diabetes for patients worldwide with a pioneering, reversible implant. EndoBarrier treatment for diabetes and obesity. Proven Results for Type 2 Diabetes and Obesity. In two separate studies, 80% of patients maintained their achieved weight loss eight months’ post-EndoBarrier removal and 77% maintained it for 12 months or more. Endobarrier treatment for diabetes and obesity following 1 year results of ABCD study. Pioneering and Simply Effective.

gidynamics.net

Default Parallels Plesk Page

Web Server's Default Page. This page is generated by Parallels Plesk. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.

gidynamics.nl

G.I. Dynamics | Your Preferred Technology Partner

gidynamics.org

Default Parallels Plesk Page

Web Server's Default Page. This page is generated by Parallels Plesk. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Parallels Plesk. Parallels is a worldwide leader in virtualization and automation software that optimizes computing for consumers, businesses, and Cloud services providers across all major hardware, operating systems, and virtualization platforms.

gidyo.com

Welcome gidyo.com - Justhost.com

Web Hosting from Just Host. Design By Design Fusions.

gidyonder.com

gidyonder

Travels and thoughts by gideon lasco. Thursday, December 20, 2012. Pangong Lake, Ladakh, India. At the shore of this beautiful lake in the Indian Himalayas, over 4000 meters above sea level, I pointed at those distant mountains and asked the locals if that area already belonged to China. The response was poignant, if subtle: "That is Tibet." Later, I found out that the locals were Tibetan refugees. The Louvre, Paris, France. To the Code of Hammurabi. Location: Paris, France. Wednesday, June 6, 2012.